Research & Publications
Kathleen Martin, PhD, graduated from Hiram College, where she majored in Biology. She earned her PhD from Case Western Reserve University in Physiology and Biophysics, then completed postdoctoral fellowships in cell biology at Harvard Medical School. Dr. Martin joined the faculty of Dartmouth Medical School in 2000 in the Section of Vascular Surgery and Department of Pharmacology where she initiated her research program studying vascular smooth muscle cell biology in cardiovascular disease. In 2009, she became an Associate Professor of Medicine and Pharmacology at Yale before becoming a professor in 2019. She has held multiple leadership positions with the American Heart Association, has served as an NIH charter study section member, and currently serves as a co-director of the Yale Cardiovascular Research Center.
Dr. Martin’s research lab aims to define the cellular signaling and epigenetic mechanisms that regualted vascular smooth muscle cell function in intimal hyperplasia, atherosclerosis, and transplant vasculopathy. Understanding how smooth muscle cells dramatically alter their phenotype may provide new insights for treatment and prevention of cardiovascular disease.
Education & Training
- Post-doctoral FellowshipHarvard Medical School (2000)
- Post-doctoral FellowshipHarvard Medical School (1998)
- PhDCase Western Reserve Univ (1997)
- BAHiram College (1990)
|AHA Vascular Discovery Vice Chair||Vice Chair||2021 - Present|
|Yale IACUC||Committee Member||2018 - 2021|
|AHA ATVB/Vascular Discovery Program Committee||Committee Member||2017 - 2021|
|AHA Founders Affiliate||Chair AHA Founders Affiliate Research Committee||2016 - 2017|
|AHA Founders Affiliate||Vice Chair AHA Founders Affiliate Research Committee||2014 - 2016|
|NIH AICS||Charter member AICS study section||2013 - 2020|
|AHA Founders Affiliate||AHA Founders Affiliate Research Committee||2011 - 2014|
|AHA Founders Affiliate||AHA Study Section - Molecular Signaling||2008 - 2013|